The clinical manifestations and treatment of sexually transmitted diseases in human immunodeficiency virus-positive men

Clinical Infectious Diseases

Volumn 32, Issue 4, 2001, Pages 611-622

  Collis, T K ^a   Celum, C L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; DOXYCYCLINE; PENICILLIN G; PROBENECID; VALACICLOVIR;

ANTIMICROBIAL THERAPY; ARTICLE; CHLAMYDIASIS; CLINICAL FEATURE; CLINICAL RESEARCH; GONORRHEA; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONSPECIFIC URETHRITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; VERRUCA VULGARIS; VIRUS TRANSMISSION; WART VIRUS;

ANTI-INFECTIVE AGENTS; HIV SEROPOSITIVITY; HUMANS; MALE; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; SEXUALLY TRANSMITTED DISEASES, VIRAL;

EID: 0035864509     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/318722     Document Type: Article

References (154)

1. Sexually transmitted diseases enhance HIV transmission: No longer a hypothesis
2. Association of sexually transmitted diseases and infection with the human immunodeficiency virus: Biological cofactors and markers of behavioral interventions
3. Epidemiological synergy: Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases
4. Primary and secondary syphilis - United States, 1997
5. Resurgent bacterial sexually transmitted disease among men who have sex with men - King County, Washington, 1997-1999
6. Elimination and reintroduction of primary and secondary syphilis
7. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus: An application of the Bradford Hill criteria
8. Treponema pallidum, lipoproteins, and synthetic lipoprotein analogues induce human immunodeficiency virus type 1 gene expression in monocytes via NF-κB activation
9. Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1
10. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
11. + cells is mediated by the chemokine receptor CC-CKR-5
12. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection
13. Lues maligna, or ulceronodular syphilis, in a man infected with human immunodeficiency virus: Case report and review
14. Unusual skin ulceration in an HIV-positive patient who had cutaneous syphilis and neurosyphilis
15. Gummatous lesions in men infected with human immunodeficiency virus and syphilis
16. Ulcerative syphilis in acquired immunodeficiency syndrome: A case of precocious tertiary syphilis in a patient infected with human immunodeficiency virus
17. Syphilitic uveitis in human immunodeficiency virus-infected patients
18. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection
19. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus
20. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection
21. Acute syphilitic meningitis: Its occurrence after clinical and serologic cure of secondary syphilis with penicillin G
22. Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus
23. The association of false-positive rapid plasma reagin results and HIV infection
24. Serologic response to treatment of syphilis in patients with HIV infection
25. False-positive tests for syphilis associated with human immunodeficiency virus and hepatitis B virus infection among intravenous drug abusers
26. False negative screening tests for syphilis in pregnant women
27. Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection
28. Specific syphilis serological tests may become negative in HIV infection
29. A prospective study of the influence of HIV status on the seroreversion of serological tests for syphilis
30. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals
31. Syphilis management and treatment
32. 1998 Guidelines for treatment of sexually transmitted diseases
33. Recrudescence of treated neurosyphilis in a patient with human immunodeficiency virus
34. Treatment of syphilis, 1998: Nonpregnant adults
35. Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women
36. Response to standard syphilis treatment in patients infected with the human immunodeficiency virus
37. Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis: Influence of concomitant human immunodeficiency virus infection
38. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection
39. Human immunodeficiency virus infection and genital ulcer disease in South Africa: The herpetic connection
40. Herpes simplex type 2 infection in the developing world
41. The high prevalence of genital herpes among patients with genital ulcer disease in Uganda
42. Increasing prevalence of genital herpes in developing countries: Implications for heterosexual HIV transmission and STI control programmes
43. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities
44. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals
45. Herpes simplex virus type 2 in the United States, 1976 to 1994
46. A seroepidemiology survey of the prevalence of herpes simplex virus type 2 infection in the United States
47. Relation between herpes simplex viruses and human immunodeficiency virus infections
48. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men
49. Transactivation of the HIV-1 LTR by HSV-1 immediate-early genes
50. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1
51. Activation of human immunodeficiency virus by herpes simplex virus
52. The association of herpes simplex virus type 2 (HSV-2), Haemophilus ducreyi, and syphilis with HIV infection in young men in northern Thailand
53. No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HW seroconversion among homosexual men
54. Herpes simplex virus type 1 as a cause of genital herpes: Impact of surveillance and prevention
55. Microbiology of human immunodeficiency virus anorectal disease
56. Sexually transmitted diseases of the colon, rectum, and anus: The challenge of the nineties
57. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men
58. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons: A double-blind, placebo-controlled trial
59. + cytotoxic T lymphocyte responses
60. + cell counts in patients with HIV infection
61. Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics
62. Genital herpes and public health: Addressing a global problem
63. Prevention agenda for genital herpes
64. Oral acyclovir for treatment of first-episode herpes simplex virus proctitis
65. New therapies and prevention strategies for genital herpes
66. Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient
67. Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS
68. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation
69. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir
70. In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus
71. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis
72. Therapy of genital human papillomavirus infections. Part 1: Indications for and justification of therapy
73. Anal warts, sexually transmitted diseases, and anorectal conditions associated with human immunodeficiency virus
74. Anal human papillomavirus infection among homosexual and bisexual men: Prevalence of type-specific infection and association with human immunodeficiency virus
75. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men
76. PCR detection of Epstein-Barr virus, herpes simplex virus and human papillomavirus from the anal mucosa in HIV-seropositive and HIV-seronegative homosexual men
77. Association of human immunodeficiency virus and anal human papillomavirus infection among homosexual men
78. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: Influence of HIV infection, immunosuppression and human papillomavirus infection
79. Effect of HIV infection on the natural history of anal human papillomavirus infection
80. Human papillomavirus infection in human immunodeficiency virus-seropositive women
81. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection
82. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women
83. Oral sex and the transmission of viral STIs
84. Hand-genital transmission of genital warts? An analysis of prevalence data
85. Circumcision and sexually transmitted diseases
86. Effect of circumcision on incidence of human immunodeficiency virus type 1 and other sexually transmitted diseases: A prospective cohort study of trucking company employees in Kenya
87. Developmental factors of urethral human papillomavirus lesions: Correlation with circumcision
88. Anal dysplasia in homosexual men: Role of anoscopy and biopsy
89. Anal and penile condylomas in HIV-negative and HIV-positive men: Clinical, histological and virological characteristics correlated to therapeutic outcome
90. Comparison of clinical, histological, and virological symptoms of HPV in HIV-1 infected men and immunocompetent subjects
91. Human papillomavirus type in anal epithelial lesions is influenced by human immunodeficiency virus
92. High grade anal dysplasia in visually normal mucosa in homosexual men: Seven cases
93. Therapeutic approaches to papillomavirus infections
94. Role of human papillomaviruses in cutaneous and oral manifestations of immunosuppression
95. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men
96. Anal cancer incidence: Genital warts, anal fissure or fistula, hemorrhoids, and smoking
97. Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men
98. Genital warts and their treatment
99. A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS
100. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients
101. Viral lesions of the mouth in HIV-infected patients
102. Surgery for anal lesions in HIV-infected patients
103. Role of highly active antiretroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1-infected patients
104. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy
105. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men
106. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: Prevalence and risk factors
107. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men
108. Sexually transmitted diseases in men who have sex with men: Acquisition of gonorrhea and non-gonococcal urethritis by fellatio and implications for STD/HIV prevention
109. An outbreak of a penicillin-sensitive strain of gonorrhoea in Sydney men
110. Sexually transmitted diseases and HIV-1 infection among homosexual men in England and Wales
111. Increases in unsafe sex and rectal gonorrhea among men who have sex with men - San Francisco, California, 1994-1997
112. Rectal gonorrhoea as an independent risk factor for HIV infection in homosexual men
113. AIDS virus infection in Nairobi prostitutes: Spread of the epidemic to East Africa
114. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study
115. Human immunodeficiency virus type 1 infection in women attending a sexually transmitted diseases clinic in Kenya
116. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1
117. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1
118. Human immunodeficiency virus DNA in urethral secretions in men: Association with gonococcal urethritis and CD4 cell depletion
119. Gonorrhoea in men: Clinical and diagnostic aspects
120. Diagnosis and treatment of sexually acquired proctitis and proctocolitis: An update
121. Disseminated penicillinase-producing Neisseria gonorrhoeae in a patient infected with human immunodeficiency virus
122. Diagnosis of rectal gonorrhoea by blind anorectal swabs compared with direct vision swabs taken via a proctoscope
123. The utility of anoscopy in the rapid diagnosis of symptomatic anorectal gonorrhea in men
124. Neisseria gonorrhoeae in Newcastle upon Tyne 1995-1997: Increase in ciprofloxacin resistance
125. Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998
126. Fluoroquinolone resistance in Neisseria gonorrhoeae, Missouri 1999
127. Nongonococcal urethritis: A new paradigm
128. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men: A randomized double-blind study
129. Trends of gonorrhea and chlamydial infection during 1985-1996 among active-duty soldiers at a united states army installation
130. Features of urethritis in a cohort of male soldiers
131. Symptomatic and asymptomatic chlamydial non-gonococcal urethritis in Jamaica: The potential for HIV transmission
132. Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma
133. HIV-1 shedding and chlamydial urethritis
134. Urethral Trichomonas vaginalis infection and HIV-1 transmission
135. Trichomonas vaginalis as a cause of urethritis in Malawian men
136. Comparison of the InPouch TV culture system and Diamond's modified medium for detection of Trichomonas vaginalis
137. Trichomonas vaginalis: No longer a minor STD
138. Trichomonas vaginalis and amplification of HIV-1 transmission
139. Sexually transmitted diseases in homosexual males in Seville, Spain
140. Infections due to species of Mycoplasma and Ureaplasma: An update
141. Association of Mycoplasma genitalium with acute non-gonococcal urethritis
142. Mycoplasma genitatium in non-gonococcal urethritis
143. Mycoplasma genitalium in males with nongonococcal urethritis: Prevalence and clinical efficacy of eradication
144. Increased frequency of detection of Ureaplasma urealyticum and Mycoplasma genitalium in AIDS patients without urethral symptoms
145. Asymptomatic non-ulcerative genital tract infections in a rural Ugandan population
146. Asymptomatic Chlamydia trachomatis urethritis in men
147. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections
148. Effect of antiretroviral therapy and viral load on the perceived risk of HIV transmission and the need for safer sexual practices
149. Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex
150. Bacterial STDs and sexual mixing of HIV-discordant men who have sex with men: A recipe for HIV transmission
151. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy
152. Determinants of human immunodeficiency virus DNA and RNA shedding in the anal-rectal canal of homosexual men
153. Compartmentalization and variability in HIV-1 shedding in blood, rectum, and pharynx
154. Per-contact risk of human immunodeficiency virus transmission between male sexual partners